3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Stomach Neoplasms
3
Pancreatic Neoplasms
3
Ovarian Neoplasms
3
Neoplasms
3
Breast Neoplasms
3
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Thyroid Neoplasms
2
Testicular Neoplasms
2
Sarcoma
2
Prostatic Neoplasms
2
Neuroendocrine Tumors
2
Lung Neoplasms
2
Esophageal Neoplasms
2
Cholangiocarcinoma
2
Carcinoma, Transitional Cell
2
Carcinoma, Hepatocellular
2
Brain Neoplasms
2
Adrenal Gland Neoplasms
2
Vaginal Neoplasms
1
Uterine Neoplasms
1
Thymus Neoplasms
1
Solitary Fibrous Tumors
1
Skin Neoplasms
1
Salivary Gland Neoplasms
1
Penile Neoplasms
1
Pancreatic Ductal Adenocarcinoma (PDAC)
1
Neoplasms, Unknown Primary
1
Hematologic Neoplasms
1
Colorectal Neoplasms
1
Interventions
Specimen Handling
9
Tamoxifen
8
Radiotherapy
6
exemestane
3
Radiation Dose Hypofractionation
3
Radiation
3
Letrozole
3
Anastrozole
3
Surveys and Questionnaires
2
Sentinel Lymph Node Biopsy
2
Radiotherapy, Intensity-Modulated
2
Radiotherapy, Conformal
2
Patient Navigation
2
Observation
2
Metformin
2
Mastectomy
2
Magnetic Resonance Spectroscopy
2
Genetic Testing
2
Biopsy
2
trastuzumab biosimilar HLX02
1
ruxolitinib
1
poly ICLC
1
palbociclib
1
fezolinetant
1
elacestrant
1
afimoxifene
1
abemaciclib
1
Trastuzumab
1
Testosterone
1
Tablets
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma, Intraductal, Noninfiltrating
×
FAPI-46
×
1 year
×
Clear all
NCT06540872
2026-06-03
MI-CISDIR
Universität Münster
Phase 2
Recruiting
30 enrolled